Dr. Anat Cohen-Dayag

President and CEO, Compugen Ltd.
Dr. Cohen-Dayag joined Compugen in 2002, and has held the positions of Vice President Research and Development, Vice President Diagnostic Biomarkers & Drug Targets, and Director of Diagnostics. In 2009, Dr. Cohen-Dayag was appointed, together with Mr. Martin Gerstel, as co-CEO of Compugen. In 2010, Dr. Cohen-Dayag was appointed Compugen’s President and Chief Executive Officer. Prior to joining Compugen, she was head of Research & Development and a member of the executive management at Mindsense Biosystems. Dr. Cohen-Dayag holds a B.S. in Biology from Ben-Gurion University, and an M.S. in chemical immunology and a Ph.D. in cellular biology from the Weizmann Institute of Science. In addition, Dr. Cohen-Dayag is a director of Ramot at Tel Aviv University Ltd.